We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
Cap. Flow
-$18.3M
Cap. Flow %
-7.71%
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.78M
2
EOG icon
EOG Resources
EOG
+$1.78M
3
COP icon
ConocoPhillips
COP
+$1.72M
4
IMO icon
Imperial Oil
IMO
+$1.64M
5
VNO icon
Vornado Realty Trust
VNO
+$1.59M

Top Sells

Rank Stock Value
1
RHP icon
Ryman Hospitality Properties
RHP
+$2.57M
2
WES icon
Western Midstream Partners
WES
+$2.52M
3
INN
Summit Hotel Properties
INN
+$2.43M
4
BEPC icon
Brookfield Renewable
BEPC
+$2.38M
5
PAC icon
Grupo Aeroportuario del Pacifico
PAC
+$2.16M

Sector Composition

Rank Sector Weight
1 Healthcare 30.46%
2 Real Estate 18.03%
3 Energy 13.68%
4 Materials 11.34%
5 Utilities 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGB
151
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
$483K 0.2%
36,252
+3,515
+11% +$46.1K
HGEN
152
DELISTED
HUMANIGEN, INC.
HGEN
$480K 0.2%
25,106
+439
+2% +$8.01K
ORTX
153
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$479K 0.2%
6,601
+117
+2% +$8.31K
VIR icon
154
Vir Biotechnology
VIR
$1.46B
$472K 0.2%
9,214
+170
+2% +$9.16K
KIO
155
KKR Income Opportunities Fund
KIO
$452M
$465K 0.2%
29,382
+911
+3% +$13.8K
PSEC icon
156
Prospect Capital
PSEC
$1.12B
$465K 0.2%
60,573
-31,463
-34% -$217K
RARE icon
157
Ultragenyx Pharmaceutical
RARE
$2.53B
$465K 0.2%
4,087
+115
+3% +$15.7K
TPVG icon
158
TriplePoint Venture Growth BDC
TPVG
$185M
$465K 0.2%
32,164
+3,232
+11% +$45.5K
NTLA icon
159
Intellia Therapeutics
NTLA
$1.46B
$462K 0.2%
5,761
+99
+2% +$6.64K
PFLT icon
160
PennantPark Floating Rate Capital
PFLT
$706M
$452K 0.19%
38,051
-2,156
-5% -$25.2K
PTCT icon
161
PTC Therapeutics
PTCT
$6.11B
$449K 0.19%
9,476
+256
+3% +$15.2K
SGEN
162
DELISTED
Seagen Inc. Common Stock
SGEN
$448K 0.19%
+3,229
New +$520K
ICPT
163
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$447K 0.19%
19,375
+526
+3% +$14.7K
HARP
164
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$445K 0.19%
2,125
+37
+2% +$7.42K
XENE icon
165
Xenon Pharmaceuticals
XENE
$6.28B
$444K 0.19%
24,819
+438
+2% +$7.42K
TVRD
166
Tvardi Therapeutics
TVRD
$23M
$437K 0.18%
560
+10
+2% +$6.85K
PLRX icon
167
Pliant Therapeutics
PLRX
$67.5M
$431K 0.18%
10,950
+191
+2% +$6.2K
RNAC icon
168
Cartesian Therapeutics
RNAC
$225M
$431K 0.18%
3,178
+56
+2% +$6.95K
ARCC icon
169
Ares Capital
ARCC
$13.7B
$428K 0.18%
22,867
+1,084
+5% +$19.5K
BSL
170
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
$428K 0.18%
27,538
+3,186
+13% +$47.4K
KPTI icon
171
Karyopharm Therapeutics
KPTI
$155M
$423K 0.18%
2,679
+73
+3% +$15.4K
MAIN icon
172
Main Street Capital
MAIN
$5.09B
$419K 0.18%
10,695
+354
+3% +$12.4K
SAR icon
173
Saratoga Investment
SAR
$314M
$419K 0.18%
16,538
+6,658
+67% +$154K
NVAX icon
174
Novavax
NVAX
$1.2B
$418K 0.18%
2,308
+33
+1% +$6.58K
EPZM
175
DELISTED
Epizyme, Inc
EPZM
$418K 0.18%
47,948
+1,310
+3% +$13.6K
5 6
7
8 9

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.

  • Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
  • Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
  • Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
  • Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
  • Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
  • Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.

Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.